{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:37:19Z","timestamp":1793299039714,"version":"4.5.0"},"reference-count":108,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>We aimed to address which antihypertensives are superior to placebo\/no therapy or another antihypertensive for controlling nonsevere pregnancy hypertension and provide future sample size estimates for definitive evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Randomized trials of antihypertensives for nonsevere pregnancy hypertension were identified from online electronic databases, to February 28, 2021 (registration URL:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.crd.york.ac.uk\/PROSPERO\/\">https:\/\/www.crd.york.ac.uk\/PROSPERO\/<\/jats:ext-link>\n                      ; unique identifier: CRD42020188725). Our outcomes were severe hypertension, proteinuria\/preeclampsia, fetal\/newborn death, small-for-gestational age infants, preterm birth, and admission to neonatal care. A Bayesian random-effects model generated estimates of direct and indirect treatment comparisons. Trial sequential analysis informed future trials needed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Of 1246 publications identified, 72 trials were included; 61 (6923 women) were informative. All commonly prescribed antihypertensives (labetalol, other \u03b2-blockers, methyldopa, calcium channel blockers, and mixed\/multi-drug therapy) versus placebo\/no therapy reduced the risk of severe hypertension by 30% to 70%. Labetalol decreased proteinuria\/preeclampsia (odds ratio, 0.73 [95% credible interval, 0.54\u20130.99]) and fetal\/newborn death (odds ratio, 0.54 [0.30\u20130.98]) compared with placebo\/no therapy, and proteinuria\/preeclampsia compared with methyldopa (odds ratio, 0.66 [0.44\u20130.99]) and calcium channel blockers (odds ratio, 0.63 [0.41\u20130.96]). No other differences were identified, but credible intervals were wide. Trial sequential analysis indicated that 2500 to 10\u2009000 women\/arm (severe hypertension or safety outcomes) to &gt;15\u2009000\/arm (fetal\/newborn death) would be required to provide definitive evidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In summary, all commonly prescribed antihypertensives in pregnancy reduce the risk of severe hypertension, but labetalol may also decrease proteinuria\/preeclampsia and fetal\/newborn death. Evidence is lacking for many other safety outcomes. Prohibitive sample sizes are required for definitive evidence. Real-world data are needed to individualize care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1161\/hypertensionaha.121.18415","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T05:00:14Z","timestamp":1641272414000},"page":"614-628","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":53,"title":["Oral Antihypertensives for Nonsevere Pregnancy Hypertension: Systematic Review, Network Meta- and Trial Sequential Analyses"],"prefix":"10.1161","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7704-1677","authenticated-orcid":true,"given":"Jeffrey N.","family":"Bone","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology, University of British Columbia (UBC), Canada (J.N.B., A.S., S.P., S.O., M.V.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5194-7892","authenticated-orcid":true,"given":"Akshdeep","family":"Sandhu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, University of British Columbia (UBC), Canada (J.N.B., A.S., S.P., S.O., M.V.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgardo D.","family":"Abalos","sequence":"additional","affiliation":[{"name":"Centro Rosarino de Estudios Perinatales, Rosario, Argentina (E.D.A.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2802-7670","authenticated-orcid":true,"given":"Asma","family":"Khalil","sequence":"additional","affiliation":[{"name":"Fetal Medicine Unit, Department of Obstetrics and Gynaecology, St George\u2019s University Hospitals, NHS Foundation Trust, United Kingdom (A.K.)."},{"name":"Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St George\u2019s University of London, United Kingdom (A.K.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7220-4382","authenticated-orcid":true,"given":"Joel","family":"Singer","sequence":"additional","affiliation":[{"name":"School of Population and Public Health, UBC, Canada (J.S.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7922-3650","authenticated-orcid":true,"given":"Sarina","family":"Prasad","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, University of British Columbia (UBC), Canada (J.N.B., A.S., S.P., S.O., M.V.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shazmeen","family":"Omar","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, University of British Columbia (UBC), Canada (J.N.B., A.S., S.P., S.O., M.V.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7633-8812","authenticated-orcid":true,"given":"Marianne","family":"Vidler","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, University of British Columbia (UBC), Canada (J.N.B., A.S., S.P., S.O., M.V.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4136-3070","authenticated-orcid":true,"given":"Peter","family":"von Dadelszen","sequence":"additional","affiliation":[{"name":"Department of Women and Children\u2019s Health, King\u2019s College London, United Kingdom (P.v.D., L.A.M.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1355-610X","authenticated-orcid":true,"given":"Laura A.","family":"Magee","sequence":"additional","affiliation":[{"name":"Department of Women and Children\u2019s Health, King\u2019s College London, United Kingdom (P.v.D., L.A.M.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002252.pub4"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1404595"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.116.07862"},{"key":"e_1_3_2_5_2","unstructured":"National Institute for Health and Care Excellence (UK). Hypertension in pregnancy: diagnosis and management [Internet]. 2019. Available at: https:\/\/www.nice.org.uk\/guidance\/ng133"},{"key":"e_1_3_2_6_2","unstructured":"WHO. WHO recommendations on drug treatment for non-severe hypertension in pregnancy. [Internet]. Geneva; 2020. Available at: https:\/\/www.who.int\/publications\/i\/item\/9789240008793"},{"key":"e_1_3_2_7_2","article-title":"Chapter 11: Undertaking network meta-analyses.","author":"Chaimani A","year":"2021","unstructured":"Chaimani, A, Caldwell, DM, Li, T, Higgins, JPT, Salnti, G. Chapter 11: Undertaking network meta-analyses. Higgins, JPT, Thomas, J, Chandler, J, Cumpston, M, Li, T, Welch, VA (eds). In Cochrane Handb Syst Rev Interv. version 6.2, Cochrane, 2021.","journal-title":"In Cochrane Handb Syst Rev Interv"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-016-1583-7"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1195"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2018.05.004"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.16319"},{"key":"e_1_3_2_12_2","unstructured":"Higgins J Thomas J Cumpston M Li T Page M Welch V. Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021) [Internet]. Cochrane; 2021. Available at: https:\/\/training.cochrane.org\/handbook\/current"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g1741"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-92298-0"},{"key":"e_1_3_2_15_2","article-title":"Bayesian random-effects meta-analysis using the bayesmeta R Package.","volume":"1","author":"R\u00f6ver C","year":"2020","unstructured":"R\u00f6ver, C. Bayesian random-effects meta-analysis using the bayesmeta R Package. J Stat Softw. 2020;1. Available at: https:\/\/www.jstatsoft.org\/v093\/i06","journal-title":"J Stat Softw"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-019-0829-2"},{"key":"e_1_3_2_17_2","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G GC. User Manual for Trial Sequential Analysis (TSA) [pdf]. [Internet]. 2017. Available at: http:\/\/www.ctu.dk\/tools-and-links\/trial-sequential-analysis.aspx"},{"key":"e_1_3_2_18_2","unstructured":"NCT02299414. Chronic Hypertension and Pregnancy (CHAP) Project (CHAP) [Internet]. 2021. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02299414"},{"key":"e_1_3_2_19_2","unstructured":"EUCTR2020-003410-12-GB. Pregnancy ANtihypertensive Drugs: which Agent is best? (Giant PANDA) [Internet]. National Institute for Health Research. 2020. Available at: https:\/\/fundingawards.nihr.ac.uk\/award\/NIHR128721"},{"key":"e_1_3_2_20_2","unstructured":"ChiCTR-IIR-17010978. Effects of different target blood pressures on maternal and fetal outcomes in non-severe chronic hypertensive pregnant women: a multicenter prospective open-labeled RCT study. 2019. Available at: http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=ChiCTR-IIR-17010978"},{"key":"e_1_3_2_21_2","unstructured":"RCT20190201042577N. The therapeutic effect of Sildenafil Citrate on maternal and fetal outcomes of pregnancies associated with severe preeclampsia [Internet]. Iranian Registry of Clinical Trials. 2019. Available at: https:\/\/en.irct.ir\/trial\/37889"},{"key":"e_1_3_2_22_2","article-title":"Comparative study of efficacy and adverse effect af labetalol and methyldopa in patients with pregnancy-induced hypertension.","volume":"45","author":"Srivastava B","year":"2013","unstructured":"Srivastava, B, Usha, R, Bhardwaj, R, Gaur, S, Joshi, G, Nag, P. Comparative study of efficacy and adverse effect af labetalol and methyldopa in patients with pregnancy-induced hypertension. Indian J Pharamcol. 2013;45.","journal-title":"Indian J Pharamcol"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.18203\/2319-2003.ijbcp20150011"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1080\/10641955.2020.1791902"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2019.05.009"},{"key":"e_1_3_2_26_2","article-title":"Editors\u2019 note in response to queries for Salama et al., Pregnancy Hypertension 2019 (PMID 31487657).","volume":"94","author":"Karumanchi A","year":"2021","unstructured":"Karumanchi, A, Hennessy, A. Editors\u2019 note in response to queries for Salama et al., Pregnancy Hypertension 2019 (PMID 31487657). Pregnancy Hypertens. 2021;94.","journal-title":"Pregnancy Hypertens"},{"key":"e_1_3_2_27_2","first-page":"335","article-title":"Treatment of hypertension during pregnancy: atenolol versus alpha-methyldopa.","volume":"43","author":"Voto LS","year":"1985","unstructured":"Voto, LS, Lapidus, AM, Neira, J, Margulies, M. Treatment of hypertension during pregnancy: atenolol versus alpha-methyldopa. Obstet y Ginecol Latino-Am. 1985;43:335\u2013341.","journal-title":"Obstet y Ginecol Latino-Am"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198700103-00025"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1990.tb01738.x"},{"key":"e_1_3_2_30_2","first-page":"133","volume-title":"6th International Congr Int Soc Study Hypertens Pregnancy","author":"Yla-Outinen A","year":"1988","unstructured":"Yla-Outinen, A. Management of pregnancy induced hypertension by using nifedipine - a prospective randomized trial. 6th International Congr Int Soc Study Hypertens Pregnancy, may 22-26, Montreal, Quebec, Canada, 1988; 133."},{"key":"e_1_3_2_31_2","first-page":"952","article-title":"[Maternal effects and perinatal safety of labetalol in the treatment of hypertension in pregnancy. Comparison with methyldopa in a randomized cooperative trial].","volume":"80","author":"Plouin PF","year":"1987","unstructured":"Plouin, PF, Br\u00e9art, G, Maillard, F, Papiernik, E, Relier, JP. [Maternal effects and perinatal safety of labetalol in the treatment of hypertension in pregnancy. Comparison with methyldopa in a randomized cooperative trial]. Arch Mal Coeur Vaiss. 1987;80:952\u2013955.","journal-title":"Arch Mal Coeur Vaiss"},{"key":"e_1_3_2_32_2","first-page":"137","article-title":"[Randomized, comparative study on the treatment of moderate arterial hypertension during pregnancy: methyldopa, acebutolol, labetalol].","volume":"81","author":"Lardoux H","year":"1988","unstructured":"Lardoux, H, Blazquez, G, Leperlier, E, G\u00e9rard, J. [Randomized, comparative study on the treatment of moderate arterial hypertension during pregnancy: methyldopa, acebutolol, labetalol]. Arch Mal Coeur Vaiss. 1988;81:137\u2013140.","journal-title":"Arch Mal Coeur Vaiss"},{"key":"e_1_3_2_33_2","first-page":"340","volume-title":"VII World Congr Hypertens Pregnancy","author":"Ciraru-Vigneron A","year":"1990","unstructured":"Ciraru-Vigneron, A, Minta, P. Comparison of nifedipine and atenolol in treatment of moderate pregnancy-hypertension. VII World Congr Hypertens Pregnancy, Perugia, Italy, Oct 7\u201311, 1990; 340."},{"key":"e_1_3_2_34_2","first-page":"354","article-title":"Nicardipine versus metoprolol in the treatment of hypertension during pregnancy: a randomized comparative trial.","volume":"84","author":"Jannet D","year":"1994","unstructured":"Jannet, D, Carbonne, B, Sebban, E, Milliez, J. Nicardipine versus metoprolol in the treatment of hypertension during pregnancy: a randomized comparative trial. Obstet Gynecol. 1994;84:354\u2013359.","journal-title":"Obstet Gynecol"},{"key":"e_1_3_2_35_2","first-page":"191","volume-title":"Proceedings of the 7th Word Congr Hypertens Pregnancy","author":"Li CY","unstructured":"Li, CY, Lao, TT, Yu, KM, Wong, SP, Leung, CF. The effect of labetalol on mild pre-eclampsia. Proceedings of the 7th Word Congr Hypertens Pregnancy. Perugia, Italy, October 1990; 191."},{"key":"e_1_3_2_36_2","volume-title":"In: Proceedings of the 2nd International Scientific Meeting of the Royal College of Obstetricians and Gynaecologists","author":"Yuen FT","unstructured":"Yuen, FT, Mo, YP, Yin, LC, Terence, L. A double-blind randomised placebo controlled trial of labetalol in the treatment of mild pregnancy induced hypertension. In: Proceedings of the 2nd International Scientific Meeting of the Royal College of Obstetricians and Gynaecologists; Hong Kong, September 1993."},{"key":"e_1_3_2_37_2","first-page":"39","article-title":"A comparative evaluation of metoprolol and methyldopa in the management of pregnancy induced hypertension.","volume":"44","author":"Oumachigui A","year":"1992","unstructured":"Oumachigui, A, Verghese, M, Balachander, J. A comparative evaluation of metoprolol and methyldopa in the management of pregnancy induced hypertension. Indian Heart J. 1992;44:39\u201341.","journal-title":"Indian Heart J"},{"key":"e_1_3_2_38_2","first-page":"44","article-title":"A randomized controlled trial on use of nimodipine in mild PIH.","volume":"52","author":"Banerjee G","year":"2002","unstructured":"Banerjee, G, Chaterjee, D, Chaterjee, A, Mukherjee, P, Das, C. A randomized controlled trial on use of nimodipine in mild PIH. J Obstet Gynecol India. 2002;52:44\u20136.","journal-title":"J Obstet Gynecol India"},{"key":"e_1_3_2_39_2","article-title":"Prospective and randomized study of mepindolol and alpha-methyldopa efficacy in arterial hypertension (AH) treatment during pregnancy.","volume":"182","author":"Casavilla F","year":"1988","unstructured":"Casavilla, F, Ruda Vega, H. Prospective and randomized study of mepindolol and alpha-methyldopa efficacy in arterial hypertension (AH) treatment during pregnancy. Proc World Congr Gynecol Obstet. 1988;182.","journal-title":"Proc World Congr Gynecol Obstet"},{"key":"e_1_3_2_40_2","first-page":"46","volume-title":"54th All India Congr Obstet Gynaecol","author":"Pandey K","year":"2011","unstructured":"Pandey, K, Gupta, N, Gupta, R, Gupta, S. Comparing obstetric outcome using labetalol\/methyldopa in pregnancy induced hypertension. 54th All India Congr Obstet Gynaecol 2011 January 5-9; Hyderabad, Andhra Pradesh, 2011; 46."},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-011-2205-2"},{"key":"e_1_3_2_42_2","first-page":"274","article-title":"A randomized, double-blind, comparative trial of nifedipine and methyldopa in moderate pregnancy induced hypertension.","volume":"5","author":"Aparna J","year":"2013","unstructured":"Aparna, J. A randomized, double-blind, comparative trial of nifedipine and methyldopa in moderate pregnancy induced hypertension. Der Pharm Lett. 2013;5:274\u2013277.","journal-title":"Der Pharm Lett"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.5455\/2320-1770.ijrcog20130205"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20151272"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1991.tb13387.x"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/0020-7292(86)90015-9"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-2243(86)90066-3"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.3109\/10641959209031044"},{"key":"e_1_3_2_49_2","first-page":"119","article-title":"Beta-adrenergic blocking agents in the treatment of pregnancy-induced hypertension.","volume":"33","author":"Paran E","year":"1995","unstructured":"Paran, E, Holzberg, G, Mazor, M, Zmora, E, Insler, V. Beta-adrenergic blocking agents in the treatment of pregnancy-induced hypertension. Int J Clin Pharmacol Ther. 1995;33:119\u2013123.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.3109\/10641958309006092"},{"key":"e_1_3_2_51_2","first-page":"373","article-title":"Evaluation of nifedipine monotherapy in the management of pregnancy hypertension.","volume":"6","author":"Catalano D","year":"1997","unstructured":"Catalano, D, ES, PF, Ascione, L, Russo, C, De Santi, B. Evaluation of nifedipine monotherapy in the management of pregnancy hypertension. G Ital Di Ostet e Ginecol. 1997;6:373\u2013375.","journal-title":"G Ital Di Ostet e Ginecol"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1998.tb10201.x"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.3109\/10641959909009615"},{"key":"e_1_3_2_54_2","first-page":"8","article-title":"Comparison between nifedipine-GITS and methyldopa on blood pressure control, utero-placental hemodynamic and fetal outcome in patients with pre-eclampsia.","volume":"19","author":"Borghi C","year":"2000","unstructured":"Borghi, C, Immordino, V, Esposti, DD. Comparison between nifedipine-GITS and methyldopa on blood pressure control, utero-placental hemodynamic and fetal outcome in patients with pre-eclampsia. Hypertens Pregnancy. 2000;19:8.","journal-title":"Hypertens Pregnancy"},{"key":"e_1_3_2_55_2","first-page":"1187","article-title":"Pregnancy induced hypertension; to compare efficacy of methyldopa and labetalol in management.","volume":"23","author":"Sharif N","year":"2016","unstructured":"Sharif, N, Usman, I, Azhar, T. Pregnancy induced hypertension; to compare efficacy of methyldopa and labetalol in management. Prof Med J. 2016;23:1187\u20131193.","journal-title":"Prof Med J"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.3109\/14767058.2013.852180"},{"key":"e_1_3_2_57_2","volume-title":"Oxford Database Perinat Trials","author":"Odendaal H","unstructured":"Odendaal, H, Schabort, I, Pattinson, R. Prazosin for the treatment of hypertension in pregnancy: a randomized control trial. Oxford Database Perinat Trials. Version 1.2 Disk 6, Autumn 1991; Chalmers, I (ed), Oxford, Oxford University Press."},{"key":"e_1_3_2_58_2","first-page":"130","volume-title":"Proceedings of the 12th Conf Priorities Perinat Care","author":"Eloff W","year":"1993","unstructured":"Eloff, W. The use of nifedipine vs methyldopa in mild to moderate pregnancy associated hypertension. Proceedings of the 12th Conf Priorities Perinat Care, South Africa. 1993;130\u2013133."},{"key":"e_1_3_2_59_2","first-page":"182","volume-title":"Proceedings of the 6th Int Congr Int Soc Study Hypertens Pregnancy","author":"Torres Pons P","unstructured":"Torres Pons, P, Roca, M, Codina, C, Cobo, E, Cararach, V, Gonzalez-Merlo, J. Labetalol in the treatment of mild hypertension in pregnancy. A double blind controlled trial. Proceedings of the 6th Int Congr Int Soc Study Hypertens Pregnancy. Montreal, Canada, May 1988;182."},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.4314\/eamj.v79i4.8872"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.291.6495.563"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365518409085385"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016348509156729"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(95)90357-7"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(68)90650-8"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(76)90597-3"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.3109\/10641968009037147"},{"key":"e_1_3_2_68_2","first-page":"148","article-title":"Labetalol in pregnancy-induced hypertension: fetal and maternal effects.","volume":"591","author":"Walker JJ","year":"1982","unstructured":"Walker, JJ, Crooks, A, Erwin, L, Calder, AA, Reily, A, Symonds, EM. Labetalol in pregnancy-induced hypertension: fetal and maternal effects. Int Congr Ser. 1982;591:148\u2013160.","journal-title":"Int Congr Ser"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198300252-00061"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.286.6382.1927"},{"key":"e_1_3_2_71_2","first-page":"168","article-title":"Randomised trial of atenolol and methyl dopa in pregnancy related hypertension.","volume":"133","author":"Thorley KJ","year":"1984","unstructured":"Thorley, KJ. Randomised trial of atenolol and methyl dopa in pregnancy related hypertension. Clin Exp Hypertens. 1984;133:168.","journal-title":"Clin Exp Hypertens"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828x.2001.tb01338.x"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1992.tb13698.x"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.301.6752.587"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.3109\/10641959109012919"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.3109\/10641950802601278"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.09972"},{"key":"e_1_3_2_78_2","first-page":"489","article-title":"Antihypertensive treatment and pregnancy outcome in patients with mild chronic hypertension.","volume":"53","author":"Arias F","year":"1979","unstructured":"Arias, F, Zamora, J. Antihypertensive treatment and pregnancy outcome in patients with mild chronic hypertension. Obstet Gynecol. 1979;53:489\u2013494.","journal-title":"Obstet Gynecol"},{"issue":"3","key":"e_1_3_2_79_2","first-page":"323","article-title":"A comparison of labetalol plus hospitalization versus hospitalization alone in the management of preeclampsia remote from term.","volume":"70","author":"Sibai BM","year":"1987","unstructured":"Sibai, BM, Gonzalez, AR, Mabie, WC, Moretti, M. A comparison of labetalol plus hospitalization versus hospitalization alone in the management of preeclampsia remote from term. Obstet Gynecol. 1987;70(3 Pt 1):323\u2013327.","journal-title":"Obstet Gynecol"},{"key":"e_1_3_2_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/0020-7292(87)90181-0"},{"key":"e_1_3_2_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(90)91297-p"},{"key":"e_1_3_2_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9378(12)80005-6"},{"key":"e_1_3_2_83_2","first-page":"85","article-title":"Comparative study of chronic hypertensive pregnant women treated and non-treated with pindolol.","volume":"8","author":"Kahhale S","year":"1985","unstructured":"Kahhale, S, ZM, CW, Paula, FJ, Sabbaga, E, Neme, B. Comparative study of chronic hypertensive pregnant women treated and non-treated with pindolol. Ginecol e Obs Bras. 1985;8:85.","journal-title":"Ginecol e Obs Bras"},{"key":"e_1_3_2_84_2","first-page":"139","article-title":"Evaluation of antihypertensives in pregnancy: prospective randomized study of mepindolol and alpha methyldopa [Evaluaci\u00f3n de antihipertensivos en embarazadas: Mepindolol y alfametildopa. Estudio prospectivo y randomizado].","volume":"48","author":"Faneite PJ","year":"1988","unstructured":"Faneite, PJ, Gonzalez, X, Salazar, G. Evaluation of antihypertensives in pregnancy: prospective randomized study of mepindolol and alpha methyldopa [Evaluaci\u00f3n de antihipertensivos en embarazadas: Mepindolol y alfametildopa. Estudio prospectivo y randomizado]. Rev Obstet Ginecol Venez. 1988;48:139\u2013143.","journal-title":"Rev Obstet Ginecol Venez"},{"key":"e_1_3_2_85_2","first-page":"157","article-title":"Comparative study with pindolol and methyldopa in pregnant women with chronic hypertension.","volume":"98","author":"Freire S","year":"1988","unstructured":"Freire, S, de Fran\u00e7a, LA, Rau de Almeida Callou, M, Alves de Oliveira, JE, Barbosa Filho, J. Comparative study with pindolol and methyldopa in pregnant women with chronic hypertension. J Bras Ginecol. 1988;98:157\u2013160.","journal-title":"J Bras Ginecol"},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000001518"},{"key":"e_1_3_2_88_2","first-page":"634","article-title":"Clonidine hydrochloride\u2013a safe and effective antihypertensive agent in pregnancy.","volume":"66","author":"Horvath JS","year":"1985","unstructured":"Horvath, JS, Phippard, A, Korda, A, Henderson-Smart, DJ, Child, A, Tiller, DJ. Clonidine hydrochloride\u2013a safe and effective antihypertensive agent in pregnancy. Obstet Gynecol. 1985;66:634\u2013638.","journal-title":"Obstet Gynecol"},{"key":"e_1_3_2_89_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2007.01315.x"},{"key":"e_1_3_2_90_2","first-page":"579","article-title":"Randomized comparison of atenolol and pindolol for treatment of hypertension in pregnancy.","volume":"44","author":"Tuimala R","year":"1988","unstructured":"Tuimala, R, Hartikainen-Sorri, A. Randomized comparison of atenolol and pindolol for treatment of hypertension in pregnancy. Curr Ther Res. 1988;44:579\u2013584.","journal-title":"Curr Ther Res"},{"key":"e_1_3_2_91_2","first-page":"260","volume-title":"Proceedings of the 6th Int Congr Int Soc Study Hypertens Pregnancy","author":"Madonna O","unstructured":"Madonna, O, M\u2019Pio, I, Labeeuw, M, Pozet, N, Zech, P. Evaluation of renal function in pregnant hypertensives under treatment. A comparison between methyldopa, pindolol and atenolol. Proceedings of the 6th Int Congr Int Soc Study Hypertens Pregnancy. Montreal, Canada, May 1988; 260."},{"key":"e_1_3_2_92_2","first-page":"99","volume-title":"Proceedings of the 6th Int Congr Int Soc Study Hypertens Pregnancy","author":"Davidson A","unstructured":"Davidson, A, Ellenbogen, A, Jaschevatzky, O, Attias, Y, Anderman, S GS. Randomized comparison of pindolol and atenolol for treatment of hypertension during pregnancy. Proceedings of the 6th Int Congr Int Soc Study Hypertens Pregnancy. Montreal, Canada, May 1988; 99."},{"key":"e_1_3_2_93_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcu.1870200205"},{"key":"e_1_3_2_94_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.304.6832.946"},{"key":"e_1_3_2_95_2","first-page":"111","volume-title":"Proceedings of the 6th Int Congr Int Soc Study Hypertens Pregnancy","author":"Loquet P","unstructured":"Loquet, P, Buytaert, P RM. The influence of pindolol and atenolol on serial feto-placental blood flow measurements in non-proteinuric hypertension in pregnancy. Proceedings of the 6th Int Congr Int Soc Study Hypertens Pregnancy, Montreal, Canada, May 1988;111."},{"key":"e_1_3_2_96_2","first-page":"1498","article-title":"Circulating biomarkers of oxidative stress in preeclampsia and efficacy of antioxidant vitamin C supplementation.","volume":"7","author":"Mujawar JR","year":"2016","unstructured":"Mujawar, JR, Patel, SS. Circulating biomarkers of oxidative stress in preeclampsia and efficacy of antioxidant vitamin C supplementation. Res J Pharm Biol Chem Sci. 2016;7:1498\u2013506.","journal-title":"Res J Pharm Biol Chem Sci"},{"key":"e_1_3_2_97_2","article-title":"A randomized trial of tight vs. less tight control of mild essential and gestational hypertension in pregnancy.","author":"El Guindy AA","year":"2020","unstructured":"El Guindy, AA, Nabhan, AF. A randomized trial of tight vs. less tight control of mild essential and gestational hypertension in pregnancy. Am J Obstet Gynecol. 2020;S0002-9378(20)30846-2.","journal-title":"Am J Obstet Gynecol"},{"key":"e_1_3_2_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.08.018"},{"key":"e_1_3_2_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.03.016"},{"key":"e_1_3_2_100_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.117.10689"},{"key":"e_1_3_2_101_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2020.02.086"},{"key":"e_1_3_2_102_2","doi-asserted-by":"publisher","DOI":"10.1002\/uog.17341"},{"key":"e_1_3_2_103_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-1235"},{"key":"e_1_3_2_104_2","doi-asserted-by":"publisher","DOI":"10.1177\/0890334419846128"},{"key":"e_1_3_2_105_2","doi-asserted-by":"publisher","DOI":"10.1093\/pch\/pxz134"},{"key":"e_1_3_2_106_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwv254"},{"key":"e_1_3_2_107_2","volume-title":"Causal Inference: What If","author":"Hern\u00e1n MA","year":"2020","unstructured":"Hern\u00e1n, MA, Robins, J. Causal Inference: What If. Chapman & Hall\/CR; 2020."},{"key":"e_1_3_2_108_2","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0338"},{"key":"e_1_3_2_109_2","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1347"},{"key":"e_1_3_2_110_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-036347"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.121.18415","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T06:09:09Z","timestamp":1715580549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.121.18415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":108,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.121.18415"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.121.18415","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"2021-10-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}